Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations.

michael rogers and danielle peterse

Find a Researcher

More than 3,000 researchers & scientific staff

Find a Researcher
find a Boston Children

Research Labs

1 million square feet of research space — and growing

Find a Center or Lab
explore Boston Children

Explore Research Topics

$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Find a Topic

Boston Children's Hospital Innovation

BCH Innovation News @BCH_Innovation 9/16/2019 8:00:00 PM
Hear how #voicetech is impacting #healthcare across industry verticals- including pharma, health plans, and health…
BCH Innovation News @BCH_Innovation 9/16/2019 5:00:01 PM
If you have a patient with #sepsis who needs surgery, you might want to check out this lab study:…
BCH Innovation News @BCH_Innovation 9/16/2019 3:30:01 PM
BORIS can emerge after #cancer is treated, and signals a poor prognosis. It forms new loops in #chromatin, activati…
BCH Innovation News @BCH_Innovation 9/16/2019 1:00:01 PM
In surgery for people with #sepsis, choice of anesthetic may matter: via @FASEBJournal…
BCH Innovation News @BCH_Innovation 9/13/2019 9:00:01 PM
Sevoflurane vs. isoflurane: Choice of #anesthesia may affect outcome in sepsis patients needing #surgery:…
BCH Innovation News @BCH_Innovation 9/13/2019 8:00:01 PM
Looping in #drugresistance and cancer relapse: Meet BORIS:
Building on our extraordinary leadership in pediatric science at Boston Children’s, we translate our findings — and those of others — to fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer